Wadia Persis P, Tambur Anat R
Transplant Immunology Laboratory, Northwestern University, Fienberg School of Medicine, 303 E Chicago Avenue, Chicago, IL, USA.
Clin Lab Med. 2008 Sep;28(3):469-79, vii-viii. doi: 10.1016/j.cll.2008.08.001.
Solid organ transplantation is the therapy of choice for end stage diseases. The alloimmune response generated after transplantation induces the production of a "cytokine storm" that can lead to either the rejection of the organ or graft acceptance. These key decisions, which determine the transplant fate, depend on the type of cytokine response (Th1/Th2). An inflammatory response will lead to graft loss; a tolerogenic response assists in graft acceptance. A balance between different factors often determines outcome. The same cytokine may assist in either allograft rejection or graft survival depending on: (1) the cell types in the vicinity, (2) the amount of each cytokine produced, (3) different sites, and (4) if it acts in a synergistic or antagonistic manner with other cytokines. This review focuses on cytokines that manipulate the alloimmune response after organ transplantation and that play a role either in graft rejection (yin) or tolerance (yang).
实体器官移植是终末期疾病的首选治疗方法。移植后产生的同种免疫反应会诱导“细胞因子风暴”的产生,这可能导致器官排斥或移植接受。这些决定移植命运的关键决策取决于细胞因子反应的类型(Th1/Th2)。炎症反应会导致移植失败;耐受反应有助于移植接受。不同因素之间的平衡往往决定结果。同一种细胞因子可能有助于同种异体移植排斥或移植存活,这取决于:(1)附近的细胞类型,(2)每种细胞因子产生的量,(3)不同的部位,以及(4)它与其他细胞因子是以协同还是拮抗方式起作用。本综述重点关注在器官移植后操纵同种免疫反应并在移植排斥(阴)或耐受(阳)中发挥作用的细胞因子。